Moreover, since the effect size (computed from mean and SD) between the control and NSCLC groups in the BCHE and GPx3 data were not high, the sensitivity and specificity (i.e., AUC in ROC analysis) of the two biomarkers are not so impressive. The gene discussed is GPX3; the disease is non-small cell lung carcinoma.